BGBon Hyuk Goo

Bon Hyuk Goo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bon Hyuk Goo has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acupotomy for Osteoarthritis of the Knee; A Systematic Review and Meta-Analysis

    by Seung Min Lee, Cham Kyul Lee, Kyung Ho Kim, Eun Jung Kim, Chan Yung Jung, Byung-Kwan Seo, Bon Hyuk Goo, Yong Hyeon Baek, Eun Yong Lee

    The purpose of this study was to evaluate the effectiveness and safety of acupotomy for the treatment of patients with knee osteoarthritis. There were 9 databases searched to retrieve randomized controlled trials until August 3, 2019 regarding acupotomy versus conventional Western medicine, conventional Western medicine treatment with and without acupotomy, and Korean medicine treatment with and without acupotomy, and meta-analysis was performed. Of 303 potentially relevant studies retrieved, 43 were systematically reviewed. All studies were conducted in China. Effective rate, visual analogue scale, and Western Ontario and McMaster Universities Osteoarthritis index were used as the evaluation scales. The Ashi point was selected most frequently. In all studies, the intervention group was more effective than the control group. Meta-analysis revealed that acupotomy showed statistically significant beneficial results. Although acupotomy had a beneficial effect on knee osteoarthritis, the risk of bias of the included studies was not low. The majority of the results from the evaluation scales used were highly heterogeneous (> 50%) which reduced confidence in the estimation of effect, or had a small sample size. Further clinical research and development is required in the future.


  • Sulfonated Poly(Ether Sulfone)-Coated and-Blended Nafion Membranes with Enhanced Performance and Reduced Hydrogen Permeability

    by BonHyuk Goo, Tae-Hyun Kim

    In the current work, thin sulfonated poly(arylene ether sulfone) (sPES)-coated Nafion membranes (The sPES-c-Nafions) are developed, for the first time, by simply spin-coating the sPES solution onto a Nafion membrane, and the results are compared with the sPES-blended Nafion counterparts. The sPES-c1-Nafion demonstrates a very high proton conductivity of 223.3 mS cm- 1 (80 °C) and very low hydrogen permeability, a 41% reduction compared to that of Nafion-212, together with improved mechanical and dimensional stabilities compared to Nafion-212. This newly developed membrane also shows excellent cell performance (i.e., with a current density of 1.56 A cm- 2 and a peak power density of 1.20 W cm- 2 at 0.6 V potential in the actual operating conditions of PEMFCs)

  • Open Access

    A Systematic Review and Meta-Analysis of Moxibustion Treatment for Knee Osteoarthritis

    by Jang Mi Park, Cham Kyul Lee, Kyung Ho Kim, Eun Jung Kim, Chan Yung Jung, Byung-Kwan Seo, Bon Hyuk Goo, Yong Hyeon Baek, Eun Yong Lee

    The purpose of this study was to evaluate the evidence supporting the effectiveness of moxibustion treatment for osteoarthritis. There were 9 databases used to retrieve randomized controlled trials (RCTs) that used moxibustion as treatment for osteoarthritis. The quality of methodology for the RCTs was assessed using the Cochrane Risk of Bias tool [Review Manager (RevMan) Version 5.3 Windows, The Nordic Cochrane Centre, Copenhagen, Denmark]. The inclusion criteria for this review was met by 27 RCTs. All studies were conducted in China. A 4-week moxibustion treatment period was the most common. EX-LE4 and SP10 and GB34 acupoints were most frequently selected in the treatment of osteoarthritis. The most commonly used evaluation index was the visual analog scale (VAS). All studies, including a meta-analysis showed that moxibustion treatments were statistically significantly effective at treating knee osteoarthritis. However, welldesigned randomized RCTs without a high risk of bias should be designed in the future.